Navigation Links
Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
Date:12/15/2009

BALTIMORE, Dec. 15 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the second fiscal quarter ended October 31, 2009. Full details of Company's financial results are available in the Company's Form 10-Q at www.championsbiotechnology.com.

Total revenues for the second quarter of 2010 were $1,289,000 as compared to $1,044,000 in fiscal 2009, an increase of 23%. The overall increase was derived from the Company's Preclinical eValuation business which generated revenues of $700,000 for the second fiscal quarter of 2010 compared to $180,000 for the corresponding quarter a year ago, an increase of 289%. Revenues from Personalized Oncology Services for the second fiscal quarter of 2010 were $589,000 as compared to $864,000 in fiscal 2009, a decrease of 32%. The overall reduction resulted from a decrease in panel revenues during the quarter partially offset by increases in Personalized Tumorgraft implantations and associated drug studies as well as vaccine studies as the Company focused on growing this more strategic area of the Personalized Oncology business.

Costs of Preclinical eValuation services for the second fiscal quarter of 2010 totaled $350,000 as compared to $90,000 in fiscal 2009. The cost of Preclinical eValuation expenses increased proportionally with the additional
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
2. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
3. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
4. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
5. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
6. Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
7. Biotechnology Salutes Americas Veterans; Innovations Continue to Offer Improved Treatment and Care of Combat Troops
8. NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations
9. Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
10. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
11. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... a peer-reviewed publication of the results of the ... (RegeneRx,s preservative-free eye drops) for the treatment of ... environment (CAE ® ) model.  The exploratory study ... which were previously disseminated by the Company in ...
(Date:5/22/2015)... 22, 2015 According to a ... Product (Consumables, Instruments, Services), by Test Type (Indirect, Enzyme-based, ... Cytometry), by End Users - Global Forecast to 2020", ... expected to reach $736.85 Million by 2020 from $452.36 ... Browse 71 market data Tables and ...
(Date:5/22/2015)... 22, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... systems ("EPS"), today announced that its CGuard TM Embolic ... investigator Prof. Piotr Musialek , at the EuroPCR ... France . PARADIGM, an investigator-initiated P ... A roti D revascularization I n symptomatic and ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... 15, 2011 This week, university hospital ... is the first hospital in the world to operate ... technology is hoped to provide surgeons with the best ... precise and safer interventions, and offering improved patient outcomes ...
... Researchers to save and organize content for mobile ... a world-leading provider of scientific, technical and medical information products ... RACK app on SciVerse Applications . Developed by ... users to save PDFs of interest in SciVerse for further ...
Cached Medicine Technology:World's First Curve™ Image Guided Surgery System Now Operating in Germany 2World's First Curve™ Image Guided Surgery System Now Operating in Germany 3Amphetamobile Develops AMMO RACK App for SciVerse Applications 2Amphetamobile Develops AMMO RACK App for SciVerse Applications 3Amphetamobile Develops AMMO RACK App for SciVerse Applications 4
(Date:5/24/2015)... May 24, 2015 Women’s Excellence ... take pressure measurements in patients’ bladder and urethra. This ... orders it if they have reported symptoms of stress ... , Women’s Excellence in Bladder Control is a comprehensive ... leakage or problems with overall control of their bladder. ...
(Date:5/24/2015)... Portsmouth, NH (PRWEB) May 24, 2015 ... faux leather, launches “InkGard™ Plus” – a classic, ... into the polymer allowing difficult stains, including ink, ... of 16 different colors suitable for corporate, healthcare, ... created in line with EnviroLeather’s goal of developing ...
(Date:5/24/2015)... Aliso Viejo, CA (PRWEB) May 24, 2015 ... for use in Final Cut Pro X. Utilize ProPin to ... locations in a given scene. , ProPin allows users ... are completely customizable in FCPX. With on-screen controls, video editors ... Studios allows users to pin and mark with absolute ease. , ...
(Date:5/24/2015)... Medicx Media Solutions http://www.medicxmedia.com ... Krihak as its head of programmatic strategy and ... expertise and leadership position in the data driven ... , Krihak is an experienced, award-winning agency and ... sales planning teams for mobile platform Jumptap. ...
(Date:5/24/2015)... CA (PRWEB) May 24, 2015 ... clear indicator that the single best option for avoiding ... reveals that fitness level was the single most powerful ... for variables such as diabetes and family history of ... of maintaining lifelong heart and lung fitness. , The ...
Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3
... Optimal Outcomes, Can Be Achieved Through ... INDIANAPOLIS, July 8 Compliance with inhaled,medications ... measured by,reduced emergency room visits and inpatient ... HealthCore, Inc., the health outcomes,research subsidiary of ...
... SUNNYVALE, Calif., July 8 ,Associates of Cape Cod, ... announce the launch of ACC,s Chromogenic LAL Endotoxin ... SoftMax(R) Pro GxP software., ACC and MDS ... part,11 solution for ACC,s Chromogenic LAL Endotoxin assay ...
... that imperils all nations", By Harvey Rubin, ... Analysis and Response (ISTAR),University of Pennsylvania School of ... is by,Harvey Rubin, M.D., Ph.D., Director of Institute ... Pennsylvania School of,Medicine:, The World Health Assembly ...
... enormous burden and amount of suffering associated with ... for health care systems in Europe today. This ... costs of mental disorders. Important factors are their ... rapid socioeconomic changes currently taking place, and, finally, ...
... DALLAS July 8, 2008 An analysis of ... time that darker-skinned patients benefit as those with lighter ... diseases, UT Southwestern Medical Center researchers show. , Phototherapy ... disorders, ranging from common problems such as acne and ...
... increase in cases, experts say , , TUESDAY, July 8 (HealthDay ... becoming pregnant does double or triple a woman,s risk, a ... in the sense that these are young women who are ... Uri Elkayam, a professor of medicine at the University of ...
Cached Medicine News:Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 2Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 3Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 4Health News:Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 2Health News:Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 3Health News:Proposing a New Global Compact for Infectious Diseases 2Health News:Proposing a New Global Compact for Infectious Diseases 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 2Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 4Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 5Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 6Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 7Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 8Health News:New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin 2Health News:Pregnancy Boosts Heart Attack Risk 2
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p...
... Universal Torso Shoulder Immobilizer ... strap. 3/8" foam with contact ... attach posteriorly. Movable wrist cuff. ... shoulder strap. Shoulder strap may ...
... Support and abduction of shoulder, elbow, ... arm and shoulder is supported by the ... 55 or 70. Foam arm support attaches ... hand support can be attached anywhere along ...
The Humeral Stabilizing System is a terrific option for immobilization of stable humeral fractures, stablesupracondular fractures, and biceps/triceps repairs....
Medicine Products: